EAN 2026: How IDH Inhibitors Are Transforming Low-Grade Glioma Treatment
In the Presidential Symposium at EAN 2026, Professor Riccardo Soffietti, Department of Neuro-Oncology, University and City of Health and Science Hospital, Turin, Italy, elaborated on 45 years of advances in low-grade glioma treatment and explained how IDH inhibitors are reshaping first-line therapy after surgery.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
